Description
PepDaddy CJC-1295 DAC 5mg is a modified growth hormone–releasing hormone (GHRH) analog studied for its extended receptor-binding characteristics in endocrine research models. The addition of Drug Affinity Complex (DAC) functionality enables prolonged interaction within receptor systems under controlled laboratory conditions.
Peptide Structure (Amino Acid Sequence)
Modified GRF (1–29) analog:
Tyr–Ala–Asp–Ala–Ile–Phe–Thr–Asn–Ser–Tyr–Arg–Lys–Val–Leu–Gly–Gln–Leu–Ser–Ala–Arg–Lys–Leu–Leu–Gln–Asp–Ile–Met–Ser–Arg
DAC modification is covalently attached to extend half-life and enhance binding duration in research models.
Research Applications
In laboratory environments, CJC-1295 DAC is utilized to investigate prolonged receptor activation, pituitary signaling dynamics, and hormone cascade interactions.
Research applications often explore:
- Sustained GHRH receptor engagement
- Endocrine signaling pathway modulation
- IGF-related biochemical frameworks
- Hormonal cascade timing and regulation
The DAC component allows researchers to examine extended signaling effects compared to non-modified peptide analogs.
Product Format
Supplied in a 5mg research-grade format, the compound is prepared for precise measurement, consistent handling, and structured experimental use.
Reconstitution & Handling Option
For laboratory convenience, an optional sterile reconstitution service is available. When selected, the compound is prepared under controlled handling conditions and provided in a research-ready format. An insulated temperature-support pouch may also be included to help maintain stability during transport and storage in temperature-sensitive environments.
Reviews
There are no reviews yet.